Clinical trial
Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing…
NCT00126464 · Cedars-Sinai Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00126464 |
|---|---|
| Title | Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing Surgery for Ductal Carcinoma in Situ of the Breast |
| Official title | A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant (Faslodex) in Breast Ductal Carcinoma (DCIS) |
| Lead sponsor | Cedars-Sinai Medical Center, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure |
| Interventions | fulvestrant, tamoxifen citrate, conventional surgery, neoadjuvant therapy |
| Enrollment | 100 |
| Start date | Nov 1, 2004 |
| First posted | Aug 4, 2005 |
| Last update posted | Nov 6, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: